The Gastrointestinal Experimental Model Systems Core is subdivided into two subcores: organoid and gnotobiotic sub-cores. The core’s centralized services support exciting scientific developments, are based on the unique expertise of the core leadership, and facilitate the use of cutting-edge model systems by DDC members. The core maintains and supplies DDC members with experiment-ready organoid cultures and gnotobiotic rodents.
The overall goal of the GEMS core is to provide DDC members with state-of-the-art experimental model systems that are difficult to initiate and maintain in independent labs. There is no similar facility in the TMC or the region. The specific aims of the GEMS core are to:
- Generate, maintain, and provide experiment-ready gastrointestinal tract organoid cultures and specialized growth reagents for membership use
- Increase the complexity of organoid models to study infection and injury
- Produce, house, manipulate, and colonize gnotobiotic animals per the needs of DDC members
- Establish housing and embryo transfer conditions to improve the overall efficiency of the gnotobiotic model.
- Establish gastrointestinal tract tissue stem cell derived organoids from new patient or animal specimens
- Provide differentiated murine and human organoids from previously established lines
- Direct intestinal differentiation of human pluripotent stem cell-derived organoids
- Maintain frozen stocks of organoids and standardized conditioned medium required for cultures
- Perform validation of lines to ensure quality control
- Transfer technology by training project members and personnel
- Explore platforms for investigating signaling among digestive organs
- Incorporate the microbiome and stromal cell types into organoid cultures
- Produce, house, and maintain germ-free rodents
- Colonize animals with microbial communities of interest
- Provide validation and microbiologic monitoring
- Provide training, outreach, and consultative services
- Develop improved housing systems and protocols that support short-term studies
- Use embryo transfer technologies that do not involve surgical procedures
Under the leadership of Sarah Blutt, Ph.D., Mary Estes, Ph.D. and Margaret Conner, Ph.D. who have extensive experience with both organoid and murine models, the GEMS core will provide a centralized facility that maintains and supplies both organoid cultures and gnotobiotic rodents. This centralization reduces cost burden for members, increases efficiency, saves time, and provides quality control for projects.